Nigeria has secured a landmark agreement to drastically cut the cost of a revolutionary HIV prevention drug, lenacapavir, paving the way for millions of citizens to access the life-saving medicine and ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...

Australia is facing a mounting sexual health crisis, with case numbers now double what they were just a decade ago.

Fiji is experiencing a concerning rise in HIV cases, placing it among the countries with the highest infection rates per ...

A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...

An HIV prevention drug will be made available at a new, low cost in 120 low- and middle-income countries starting in 2027, according to an announcement yesterday. The move is being called a “once-in-a ...

A CDC report from July 22, 2025, details the largest recorded outbreak of fungal meningitis linked to medical tourism in the ...

Linda-Gail Bekker, who helped prove the drug Lenacapavir’s effectiveness, tells The Independent that $40 doses bring hope – ...

Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be ...